Revista chilena de obstetricia y ginecología
On-line version ISSN 0717-7526
OVALLE S, Alfredo et al. EPIDEMIOLOGÍA, RESULTADOS CLÍNICOS Y COSTOS DEL TRATAMIENTO DEL ABSCESO TUBOOVÁRICO, EN UN HOSPITAL PÚBLICO DE SANTIAGO. Rev. chil. obstet. ginecol. [online]. 2008, vol.73, n.6, pp. 374-380. ISSN 0717-7526. doi: 10.4067/S0717-75262008000600004.
Objective: To determine frequency and risk factors of tuboovarian abscess (TOA) and observe complica-tions, fertility damages and surgical costs of medical-surgical treatment. Method: Retrospective study in 64 patients operated with TOA diagnosis. Patients were managed with medical-surgical treatment: use of antibiotics and then surgery in cases of peritonitis diffuse, persistent fever with palpable mass and adnexial mass greater than 6 cm without fever. They were evaluated in future fertility and complications: infection and of surgical wound dehiscence, reoperation by residual TOA, intestinal injury, bladder injury and medical complications. Results: The TOA accounted for 73.6% of hospitalized cases of pelvic inflammatory disease (PID), 1.5 cases per month and 17.2% of actinomycosis. The mean age of patients was 40.5 years. The intrauterine device (IUD) was associated with TOA in 84.4% of cases, 94.4% uncontrolled and with a 10.2 years mean use. The unilateral TOA was the most frequent (57.8%) and the unilateral anexectomy the most common operation. The 17.2% of patients presented complications and 85.9% remained infertile. These results showed an increase compared with those obtained in the series published in 1993. The total cost of the 64 cases was $86.331.713 (UF 3.788), with a mean of $1.348.933 (UF 59.2). Conclusión: There is an increased frequency of the TOA and of pelvic actinomycosis, with consequent increase of infertility and costs associated with the uncontrolled and long-term use of IUD.
Keywords : Tuboovarian abscess; intrauterine device; actinomycosis.